2021 June 23
1.
Translation of the poly(GR) frame in C9ORF72-ALS/FTD is regulated by cis-elements involved in alternative splicing. Lampasona A, Almeida S, Gao FB.
Neurobiol Aging. 2021 May 8;105:327-332. doi: 10.1016/j.neurobiolaging.2021.04.030. Online ahead of print.
PMID: 34157654
2.
Dual-task speech performance in multiple sclerosis. Feenaughty L.
Mult Scler Relat Disord. 2021 Jun 10;53:103077. doi: 10.1016/j.msard.2021.103077. Online ahead of print.
PMID: 34157630
3.
Using the multiple sclerosis resiliency scale to identify psychological distress in persons with multiple sclerosis. Gromisch ES, Neto LO, Sloan J, Tyry T, Foley FW.
Mult Scler Relat Disord. 2021 Jun 11;53:103079. doi: 10.1016/j.msard.2021.103079. Online ahead of print.
PMID: 34157629
4.
Retraction: Nutritional and Biochemical Parameters Among Multiple Sclerosis Patients: A Case-Control Study. Salman A, Islam S, Saleh MA, Bhinder KK, Malik Z, Tahir I, Naveed MA.
Cureus. 2021 May 27;13(5):r31. doi: 10.7759/cureus.r31.
PMID: 34157058 Free PMC article.
5.
The clinical correlates of the chair sit to stand performance in people with multiple sclerosis. Khalil H, Rehan R, Al-Sharman A, El-Salem K.
Physiother Theory Pract. 2021 Jun 22:1-12. doi: 10.1080/09593985.2021.1931590. Online ahead of print.
PMID: 34156901
6.
Serum endocan levels in multiple sclerosis relapse and remission. Akil E, Alp R, Aluclu MU, Acar A, Kaplan I.
Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4091-4098. doi: 10.26355/eurrev_202106_26051.
PMID: 34156688
7.
A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report. Mäkitie RE, Pekkinen M, Morisada N, Kobayashi D, Yonezawa Y, Nishimura G, Ikegawa S, Mäkitie O.
Calcif Tissue Int. 2021 Jun 22. doi: 10.1007/s00223-021-00878-5. Online ahead of print.
PMID: 34156493
8.
Plant derived cyclic peptides. Daly NL, Wilson DT.
Biochem Soc Trans. 2021 Jun 22:BST20200881. doi: 10.1042/BST20200881. Online ahead of print.
PMID: 34156400
9.
Towards an objective classification of multiple sclerosis. Eshaghi A.
Mult Scler. 2021 Jul;27(8):1151-1152. doi: 10.1177/1352458520975325. Epub 2020 Dec 2.
PMID: 34156317 No abstract available.
10.
Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis. ‚t Hart BA, Luchicchi A, Schenk GJ, Stys PK, Geurts JJG.
Ann Clin Transl Neurol. 2021 Jun 22. doi: 10.1002/acn3.51401. Online ahead of print.
PMID: 34156169 Review.
11.
Anti-N-methyl-D-aspartate receptor encephalitis in a patient with multiple sclerosis on dimethyl fumarate: a case report. Seyed Ahadi M, Ghadiri F, Sahraian MA, Naser Moghadasi A.
Neurol Sci. 2021 Jun 22. doi: 10.1007/s10072-021-05385-x. Online ahead of print.
PMID: 34155564 No abstract available.
12.
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19. Inshasi J, Alroughani R, Al-Asmi A, Alkhaboury J, Alsalti A, Boshra A, Canibano B, Deleu D, Ahmed SF, Shatila A, Thakre M.
Neurol Ther. 2021 Jun 17:1-17. doi: 10.1007/s40120-021-00260-5. Online ahead of print.
PMID: 34155473 Free PMC article. Review.
13.
Nutritional and Biochemical Parameters Among Multiple Sclerosis Patients: A Case-Control Study. Salman A, Islam S, Saleh MA, Bhinder KK, Malik Z, Tahir I, Naveed MA.
Cureus. 2021 May 19;13(5):e15108. doi: 10.7759/cureus.15108.
PMID: 34155466 Free PMC article. Retracted.
14.
The multiple sclerosis prodrome. Makhani N, Tremlett H.
Nat Rev Neurol. 2021 Jun 21. doi: 10.1038/s41582-021-00519-3. Online ahead of print.
PMID: 34155379 Review.
15.
Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study. Grau J, Zöllner JP, Schubert-Bast S, Kurlemann G, Hertzberg C, Wiemer-Kruel A, Bast T, Bertsche A, Bettendorf U, Fiedler B, Hahn A, Hartmann H, Hornemann F, Immisch I, Jacobs J, Kieslich M, Klein KM, Klotz KA, Kluger G, Knuf M, Mayer T, Marquard K, Meyer S, Muhle H, Müller-Schlüter K, Noda AH, Ruf S, Sauter M, Schlump JU, Syrbe S, Thiels C, Trollmann R, Wilken B, Willems LM, Rosenow F, Strzelczyk A.
Orphanet J Rare Dis. 2021 Jun 21;16(1):282. doi: 10.1186/s13023-021-01899-x.
PMID: 34154622
16.
Neutrophil-Derived Myeloperoxidase Facilitates Both the Induction and Elicitation Phases of Contact Hypersensitivity. Strzepa A, Gurski CJ, Dittel LJ, Szczepanik M, Pritchard KA Jr, Dittel BN.
Front Immunol. 2021 Jan 25;11:608871. doi: 10.3389/fimmu.2020.608871. eCollection 2020.
PMID: 33569056 Free PMC article.
2021 June 22
1.
Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-κB signal pathway. Yan N, Xu Z, Qu C, Zhang J.
Int Immunopharmacol. 2021 Jun 18;98:107844. doi: 10.1016/j.intimp.2021.107844. Online ahead of print.
PMID: 34153667
2.
The burden of neurological comorbidities in six autoimmune bullous diseases: A population-based study. Kridin K, Hübner F, Recke A, Linder R, Schmidt E.
J Eur Acad Dermatol Venereol. 2021 Jun 21. doi: 10.1111/jdv.17465. Online ahead of print.
PMID: 34153122
3.
The blood-brain and gut-vascular barriers: from the perspective of claudins. Scalise AA, Kakogiannos N, Zanardi F, Iannelli F, Giannotta M.
Tissue Barriers. 2021 Jun 21:1926190. doi: 10.1080/21688370.2021.1926190. Online ahead of print.
PMID: 34152937
4.
Genetic diseases mimicking multiple sclerosis. Lin HC, Iwanowski P, Hsuan HC, Kozubski W.
Postgrad Med. 2021 Jun 21. doi: 10.1080/00325481.2021.1945898. Online ahead of print.
PMID: 34152933
5.
T cell transgressions: tales of T cell form and function in diversedisease states. Harris KM, Clements MA, Kwilasz AJ, Watkins LR.
Int Rev Immunol. 2021 Jun 21:1-42. doi: 10.1080/08830185.2021.1921764. Online ahead of print.
PMID: 34152881
6.
Potential for the Repurposing of Adamantane Antivirals for COVID-19. Butterworth RF.
Drugs R D. 2021 Jun 21. doi: 10.1007/s40268-021-00351-6. Online ahead of print.
PMID: 34152583 Review.
7.
Risk and outcomes of covid-19 in patients with multiple sclerosis. Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Muñoz JS, Aladro Y, Cárcamo Fonfría A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez M, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM.
Eur J Neurol. 2021 Jun 21. doi: 10.1111/ene.14990. Online ahead of print.
PMID: 34152073
8.
Clinical and Neuroimaging Findings in MOGAD – MRI and OCT. Bartels F, Lu A, Oertel FC, Finke C, Paul F, Chien C.
Clin Exp Immunol. 2021 Jun 21. doi: 10.1111/cei.13641. Online ahead of print.
PMID: 34152000 Review.
9.
Participant experiences of eight weeks of supervised or home-based Pilates among people with multiple sclerosis: a qualitative analysis. Fleming KM, Herring MP, Coote SB, Tindall D.
Disabil Rehabil. 2021 Jun 19:1-8. doi: 10.1080/09638288.2021.1939446. Online ahead of print.
PMID: 34151667
10.
Analytical design of multi-threshold and high fan-in DNA-based logical sensors to profile the pattern of MS microRNAs. Sanjabi M, Jahanian A.
Biomed Eng Lett. 2021 May 11;11(2):131-145. doi: 10.1007/s13534-021-00186-9. eCollection 2021 May.
PMID: 34150349
11.
The relationship between the carotid atherosclerosis ultrasound parameters and the cardiac and endothelial functions of coronary heart disease patients. Song Q, Guo Y, Pei F, Wang X.
Am J Transl Res. 2021 May 15;13(5):5498-5504. eCollection 2021.
PMID: 34150149 Free PMC article.
12.
Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease. Na SY, Krishnamoorthy G.
Front Immunol. 2021 Jun 2;12:668487. doi: 10.3389/fimmu.2021.668487. eCollection 2021.
PMID: 34149706 Free PMC article.
13.
Brainstem Involvement in Amyotrophic Lateral Sclerosis: A Combined Structural and Diffusion Tensor MRI Analysis. Li H, Zhang Q, Duan Q, Jin J, Hu F, Dang J, Zhang M.
Front Neurosci. 2021 Jun 2;15:675444. doi: 10.3389/fnins.2021.675444. eCollection 2021.
PMID: 34149349 Free PMC article.
14.
Interventions for promoting physical activity in people with neuromuscular disease. Jones K, Hawke F, Newman J, Miller JA, Burns J, Jakovljevic DG, Gorman G, Turnbull DM, Ramdharry G.
Cochrane Database Syst Rev. 2021 May 24;5(5):CD013544. doi: 10.1002/14651858.CD013544.pub2.
PMID: 34027632
15.
Non-drug therapies for the secondary prevention of lower limb muscle cramps. Hawke F, Sadler SG, Katzberg HD, Pourkazemi F, Chuter V, Burns J.
Cochrane Database Syst Rev. 2021 May 17;5(5):CD008496. doi: 10.1002/14651858.CD008496.pub3.
PMID: 33998664
16.
The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder. Maghbooli Z, Naser Moghadasi A, Rezaeimanesh N, Omidifar A, Varzandi T, Sahraian MA.
BMC Neurol. 2021 Apr 20;21(1):167. doi: 10.1186/s12883-021-02198-5.
PMID: 33879088 Free PMC article.
17.
Generation of Neurosphere-Derived Organoid-Like-Aggregates (NEDAS) from Neural Stem Cells. Watanabe F, Schoeffler A, Fair SR, Hester ME, Fedorko J, Imitola J.
Curr Protoc. 2021 Feb;1(2):e15. doi: 10.1002/cpz1.15.
PMID: 33534198
18.
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y, Nishiyama S, Abe M, Ishii T, Aoki M, Nakashima I.
J Neurol. 2021 May;268(5):1938-1944. doi: 10.1007/s00415-020-10377-6. Epub 2021 Jan 8.
PMID: 33416998
19.
NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab. Martin T, Duke S, Kumar V, Fadhil A, Ibrahim R, Palmer K, Yazdani S, Devereaux M, Gunzler S, Serra A, Abboud H.
J Neurol. 2021 Feb;268(2):714-716. doi: 10.1007/s00415-020-10341-4. Epub 2021 Jan 2.
PMID: 33388924 No abstract available.
20.
Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report. Lazzarin SM, Cannizzaro M, Russo T, Sangalli F, Callea M, Colombo B, Moiola L, Filippi M.
J Neurol. 2020 Dec;267(12):3773-3775. doi: 10.1007/s00415-020-10296-6. Epub 2020 Nov 3.
PMID: 33141250 Free PMC article. No abstract available.
2021 June 21
1.
Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: A systematic review and meta-analysis. Rice EM, Thakolwiboon S, Avila M.
Mult Scler Relat Disord. 2021 May 24;53:103024. doi: 10.1016/j.msard.2021.103024. Online ahead of print.
PMID: 34148006
2.
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies. Cree BAC, Pradhan A, Pei J, Williams MJ; OPERA I and OPERA II clinical investigators.
Mult Scler Relat Disord. 2021 May 7;52:103010. doi: 10.1016/j.msard.2021.103010. Online ahead of print.
PMID: 34147885
3.
Palliative Care Intervention Trials for Adults Living with Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review. Leeper HE, Diane Cooper I, Armstrong TS.
J Pain Symptom Manage. 2021 Jun 17:S0885-3924(21)00386-9. doi: 10.1016/j.jpainsymman.2021.06.010. Online ahead of print.
PMID: 34147576 Review.
2021 June 20
1.
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression. De Brouwer E, Becker T, Moreau Y, Havrdova EK, Trojano M, Eichau S, Ozakbas S, Onofrj M, Grammond P, Kuhle J, Kappos L, Sola P, Cartechini E, Lechner-Scott J, Alroughani R, Gerlach O, Kalincik T, Granella F, Grand’Maison F, Bergamaschi R, José Sá M, Van Wijmeersch B, Soysal A, Sanchez-Menoyo JL, Solaro C, Boz C, Iuliano G, Buzzard K, Aguera-Morales E, Terzi M, Trivio TC, Spitaleri D, Van Pesch V, Shaygannejad V, Moore F, Oreja-Guevara C, Maimone D, Gouider R, Csepany T, Ramo-Tello C, Peeters L.
Comput Methods Programs Biomed. 2021 May 18;208:106180. doi: 10.1016/j.cmpb.2021.106180. Online ahead of print.
PMID: 34146771
2.
Dynamic nanoassemblies for imaging and therapy of neurological disorders. Zhang L, Sun H, Zhao J, Lee J, Ee Low L, Gong L, Chen Y, Wang N, Zhu C, Lin P, Liang Z, Wei M, Ling D, Li F.
Adv Drug Deliv Rev. 2021 Jun 16:113832. doi: 10.1016/j.addr.2021.113832. Online ahead of print.
PMID: 34146626 Review.
3.
Multiple sclerosis under the spotlight. The Lancet Neurology.
Lancet Neurol. 2021 Jul;20(7):497. doi: 10.1016/S1474-4422(21)00170-8.
PMID: 34146496 No abstract available.
4.
Understanding Polyomavirus CNS Disease – a Perspective from Mouse Models. Ayers KN, Carey SN, Lukacher AE.
FEBS J. 2021 Jun 19. doi: 10.1111/febs.16083. Online ahead of print.
PMID: 34145975 Review.
5.
Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, Amor S.
Glia. 2021 Jun 19. doi: 10.1002/glia.24052. Online ahead of print.
PMID: 34145928
6.
EBI2 is expressed in glial cells in multiple sclerosis lesions and its knock-out modulates remyelination in the cuprizone model. Klejbor I, Shimshek DR, Klimaszewska-Łata J, Velasco-Estevez M, Moryś J, Karaszewski B, Szutowicz A, Rutkowska A.
Eur J Neurosci. 2021 Jun 19. doi: 10.1111/ejn.15359. Online ahead of print.
PMID: 34145920
7.
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl CA, Zhu J, Jandreski L, Cullen P, Carlile TM, Li A, Rebollar JV, Sybulski J, Reynolds TL, Zhang B, Basile R, Tang H, Harp CP, Pellerin A, Silbereis J, Franchimont N, Cahir-McFarland E, Ransohoff RM, Cameron TO, Mingueneau M.
Brain. 2021 Jun 18:awab231. doi: 10.1093/brain/awab231. Online ahead of print.
PMID: 34145876